Page 6 - Hyperion Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hyperion capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hyperion Capital Today - Breaking & Trending Today

IM Cannabis to Acquire Canadian LP MYM Nutraceuticals for $87 Million in Stock – New Cannabis Ventures


April 1, 2021 at 9:52 am
Published by NCV Newswire
IM Cannabis to Acquire MYM Nutraceuticals and Its Licensed Producer Subsidiary, Highland Grow
Highland Grow is currently profitable on an EBITDA basis and the Transaction is expected to be immediately accretive to IMC
Highland Grow is expected to generate net revenue of $29 million and $38 million and gross margins of 34% to 36% in 2021 and 2022, respectively
[1]
Purchase price implies 2.3x net revenue and 6.7x EBITDA in 2022 with synergies
MYM shareholders will receive 0.022 IMC shares for each MYM share, representing a price of $0.195 based on respective closing prices on March 31, 2021
Super premium positioning, complementary brands, enhanced distribution and export opportunities to Israel and European markets ....

United States , United Kingdom , Nova Scotia , British Columbia , Adjupharm Gmb , Michael Wiener , Oren Shuster , Im Cannabis Corp , International Financial Reporting Standards , Committee On , Borden Ladner Gervais , Sublimeculture Inc , Acquisition Corp , Cassels Graydon , Hyperion Capital Inc , Biome Grow Inc , Dentons Canada , Highland Grow Inc , Canadian Securities Exchange , Nutraceuticals Inc , Its Licensed Producer Subsidiary , Highland Grow , Business Corporations Act , Eastern Canada , Multilateral Instrument , Minority Security Holders ,